⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23829690 | 0.71 | — | — | |
| SCHEMBL7055838 | 0.71 | — | — | |
| SCHEMBL2701192 | 0.71 | — | — | |
| SCHEMBL16436873 | 0.71 | — | — | |
| SCHEMBL24439848 | 0.69 | — | — | |
| SCHEMBL27697046 | 0.67 | — | — | |
| SCHEMBL7168792 | 0.67 | — | — | |
| SCHEMBL23761696 | 0.67 | — | — | |
| SCHEMBL10557403 | 0.67 | — | — | |
| SCHEMBL1758271 | 0.65 | EGLN1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595314-B2 | Antibody specific for GPC3 and methods of use thereof | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250084182-A1 | ANTIBODY SPECIFIC FOR MUCIN-1 AND METHODS OF USE THEREOF | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2025-03-13 | — | — | US | disclosed |
| US-12116409-B2 | Antibody specific for CD22 and methods of use thereof | REDWOOD BIOSCIENCE, INC. (US) | 2024-10-15 | — | — | US | disclosed |
| US-11970546-B2 | Antibody specific for Mucin-1 and methods of use thereof | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-04-30 | — | — | US | disclosed |
| CN-116322770-A | Antibodies specific for mucin-1 and methods of use thereof | R·P·舍勒科技有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4188432-A1 | ANTIBODY SPECIFIC FOR MUCIN-1 AND METHODS OF USE THEREOF | R.P. Scherer Technologies, LLC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20220251237-A1 | Antibody Specific for GPC3 and Methods of Use Thereof | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2022-08-11 | — | — | US | disclosed |
| US-20220220198-A1 | ANTIBODY SPECIFIC FOR CD22 AND METHODS OF USE THEREOF | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2022-07-14 | — | — | US | disclosed |
| EP-4007604-A1 | ANTIBODY SPECIFIC FOR GPC3 AND METHODS OF USE THEREOF | R.P. Scherer Technologies, LLC (US) | 2022-06-08 | — | — | EP | disclosed |
| CN-114340671-A | Antibodies specific for GPC3 and methods of use thereof | R.P.谢勒技术有限责任公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20110287041-A1 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-11-24 | — | — | US | disclosed |
| US-20110250704-A1 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-10-13 | — | — | US | disclosed |
| US-7985783-B2 | Aldehyde tags, uses thereof in site-specific protein modification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-07-26 | — | — | US | disclosed |
| US-20110117621-A1 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-05-19 | — | — | US | disclosed |
| US-20110111443-A1 | APPARATUS FOR AUTO-PRETREATING SUGAR CHAIN | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2011-05-12 | — | — | US | disclosed |
| EP-2207030-A1 | APPARATUS FOR AUTO-PRETREATING SUGAR CHAIN | Hokkaido University (JP) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009120611-A2 | ALDEHYDE TAGS, USES THEREOF IN SITE-SPECIFIC PROTEIN MODIFICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-10-01 | — | — | WO | disclosed |
| EP-2064334-A2 | ALDEHYDE TAGS, USES THEREOF IN SITE-SPECIFIC PROTEIN MODIFICATION | The Regents of the University of California (US) | 2009-06-03 | — | — | EP | disclosed |
| US-20080187956-A1 | Modification at sulfatase motif of aldehyde tag through action of a formylglycine generating enzyme (FGE) generates formylglycine (FGly) residue | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-08-07 | — | — | US | disclosed |
| WO-2008036350-A2 | ALDEHYDE TAGS, USES THEREOF IN SITE-SPECIFIC PROTEIN MODIFICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-03-27 | — | — | WO | disclosed |